Morgan Lewis

Life Sciences Protecting the Complete Life Cycle

For More Information

Read the Brochure

Life Sciences and Healthcare

New Resource

Healthcare Policy and Reform Resource Center

Life Sciences Deskbook

Compliance Resources

New Resource: Health Industry Transparency Compliance Resource Center

Emerging Business Tools

visit the Entrepreneur Resource Headquarters

Honors

LMG Life Sciences’s Healthcare Pricing and Reimbursement Firm of 2013

LMG Life Sciences 2013

  • Antitrust – Highly Recommended
  • Competition and Antitrust – Recommended
  • Corporate – Highly Recommended
  • FDA & Pharmaceutical – Recommended
  • General Patent Litigation – Recommended
  • Government Investigation/Fraud & Abuse – Highly Recommended
  • Healthcare: Pricing & Reimbursement – Recommended
  • Licensing & Collaboration (non-university) – Highly Recommended
  • Life Cycle Firm of the Year
  • Mega-Mergers – Recommended
  • Patent Prosecution – Recommended

Chambers Global 2013

  • Global Life Sciences – Recommended, Band 3

Chambers USA 2014

  • National for Life Sciences – Tier 3
  • Washington, D.C., for Healthcare – Pharmaceutical/Medical Products Regulatory – Tier 3

American Health Lawyers Association (AHLA) 2013

  • Top 20 largest U.S. AHLA firm
  • Largest AHLA firm in Pennsylvania
  • One of the largest firms participating in the AHLA Practice Groups of Labor and Life Sciences

Modern Healthcare 2014

  • Ranked 2nd in the Healthcare Law Firms Survey

PLC Cross-border 2012 Life Sciences Legal Market Review

  • Life Sciences Super League – Ranked 14th of law firms worldwide
  • Life Sciences Regulatory Super League – Ranked 8th of law firms worldwide

PLC Life Sciences Multi-Jurisdictional Guide 2012

United States:

  • Commercial and Partnering – Highly Recommended
  • Competition/Antitrust – Highly Recommended
  • Corporate – Recommended
  • Government Enforcement and Investigations – Highly Recommended
  • Pricing and Reimbursement – Recommended
  • Regulatory – Recommended
  • Regulatory (Medical Devices) – Recommended

England:

  • Regulatory – Highly Recommended

Japan:

  • Corporate and Commercial – Recommended

Clients

17 of the top 20 pharmaceutical companies

8 of the top 20 biotechnology companies

13 of the top 20 medical device companies

11 of the top 20 food/beverage companies

Practice Highlights

Related News

07/24/14 Biosimilars Clarity Coming as FDA Eyes Sandoz Application, Law360
FDA partner Stephen Paul Mahinka is quoted regarding the FDA's landmark decision that should answer how copycat products will be named and deemed interchangeable with their branded counterparts.
07/03/14 Morgan Lewis Ranked One of the Largest Healthcare Law Firms in the U.S.
For the third connective year, Morgan Lewis was ranked one of the largest U.S. law firms in the healthcare industry by leading healthcare business and policy news magazine Modern Healthcare .
07/02/14 Morgan Lewis Advises on Minerva Neurosciences IPO
A team of Morgan Lewis lawyers advised Minerva Neurosciences Inc. on its initial public offering of nearly 5.5 million shares.
View all news

Related Publications

08/25/14 Medical Device Update: FDA Issues Draft Guidance on Streamlined De Novo Classification Process
The draft provides guidance on a streamlined process for submitting requests to the FDA to down-classify certain low-to-moderate-risk devices that have been automatically classified as Class III.
08/04/14 FDA Issues Updated Draft Guidance on Reporting Drug Samples
The guidance calls for 2014 reporting by April 1, 2015.
View all publications

Comprising more than 175 partners and counsel located in the United States, Europe, and Asia, Morgan Lewis’s Life Sciences and Healthcare Practice is one of the most comprehensive practices in the world—serving more than 1,100 clients throughout the complete product life cycle and in all facets of industry issues. The strength of our team is supported by more than 50 professionals holding advanced scientific degrees.

Our clients include many of the largest and most successful pharmaceutical companies in the world, as well as a variety of biotechnology companies, medical device manufacturers, nutritional companies, healthcare providers, renowned research and scientific institutions, and life sciences–focused investment banks and venture capital firms. As diverse as they are, these companies share a common need for comprehensive, integrated legal services that address all of the business challenges and opportunities facing the industry.

Our Life Sciences and Healthcare Practice focuses on all important areas, from transactions and litigation to regulatory approvals and compliance and protection of intellectual property, as well as key supporting capabilities, including FDA and healthcare, patents and patent litigation, labor and employment law, Morgan Lewis Resources workplace training and immigration, and antitrust. As a full-service firm with offices in the financial and regulatory centers of importance to the industry globally, we are consistently recognized as an industry leader by Chambers USA, Chambers Global, Modern Healthcare, The Legal 500, and other industry observers.